Autobio Diagnostics Co., Ltd. (SHA:603658)
China flag China · Delayed Price · Currency is CNY
39.30
-0.03 (-0.08%)
May 13, 2025, 1:45 PM CST
-29.63%
Market Cap 22.47B
Revenue (ttm) 4.38B
Net Income (ttm) 1.14B
Shares Out 571.42M
EPS (ttm) 1.98
PE Ratio 19.86
Forward PE 18.12
Dividend 1.26 (3.21%)
Ex-Dividend Date Jun 5, 2024
Volume 1,411,990
Average Volume 2,428,209
Open 39.47
Previous Close 39.33
Day's Range 39.25 - 39.60
52-Week Range 37.56 - 57.64
Beta -0.04
RSI 40.64
Earnings Date Apr 18, 2025

About Autobio Diagnostics

Autobio Diagnostics Co., Ltd. engages in the research and development, production, marketing, sale, and service of clinical diagnostic products in China and internationally. The company offers immunoassay, biochemistry, and microbiology products; reagents and instruments; and technical and support, and training services, as well as engages in biology research and development activities. Its immunoassay products consist of AutoLumo S900 and AutoLumo A1860 that provides user experience for small and medium size labs; AutoLumo A6200/A6600, an auto... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 1998
Employees 5,773
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603658
Full Company Profile

Financial Performance

In 2024, Autobio Diagnostics's revenue was 4.47 billion, an increase of 0.62% compared to the previous year's 4.44 billion. Earnings were 1.19 billion, a decrease of -1.89%.

Financial Statements

News

There is no news available yet.